These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24293034)

  • 21. Heart Failure-Induced Skeletal Muscle Wasting.
    Philippou A; Xanthis D; Chryssanthopοulos C; Maridaki M; Koutsilieris M
    Curr Heart Fail Rep; 2020 Oct; 17(5):299-308. PubMed ID: 32743732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone deficiency and exercise intolerance in heart failure: treatment implications.
    Iellamo F; Rosano G; Volterrani M
    Curr Heart Fail Rep; 2010 Jun; 7(2):59-65. PubMed ID: 20424990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
    Anker SD; Coats AJ
    Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.
    Piepoli MF; Guazzi M; Boriani G; Cicoira M; Corrà U; Dalla Libera L; Emdin M; Mele D; Passino C; Vescovo G; Vigorito C; Villani G; Agostoni P;
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):643-8. PubMed ID: 21217245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations.
    Duscha BD; Kraus WE; Keteyian SJ; Sullivan MJ; Green HJ; Schachat FH; Pippen AM; Brawner CA; Blank JM; Annex BH
    J Am Coll Cardiol; 1999 Jun; 33(7):1956-63. PubMed ID: 10362199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise intolerance.
    Kitzman DW
    Prog Cardiovasc Dis; 2005; 47(6):367-79. PubMed ID: 16115516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.
    Conraads VM; Van Craenenbroeck EM; De Maeyer C; Van Berendoncks AM; Beckers PJ; Vrints CJ
    Heart Fail Rev; 2013 Jan; 18(1):65-77. PubMed ID: 22684340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach.
    Pasini E; Aquilani R; Gheorghiade M; Dioguardi FS
    Ital Heart J; 2003 Apr; 4(4):232-5. PubMed ID: 12784775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional strategy in the management of heart failure in adults.
    Bourdel-Marchasson I; Emeriau JP
    Am J Cardiovasc Drugs; 2001; 1(5):363-73. PubMed ID: 14728018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic heart failure and skeletal muscle catabolism: effects of exercise training.
    Schulze PC; Gielen S; Schuler G; Hambrecht R
    Int J Cardiol; 2002 Sep; 85(1):141-9. PubMed ID: 12163219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity.
    Larsen AI; Lindal S; Aukrust P; Toft I; Aarsland T; Dickstein K
    Int J Cardiol; 2002 Apr; 83(1):25-32. PubMed ID: 11959380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal myopathy in heart failure: effects of aerobic exercise training.
    Brum PC; Bacurau AV; Cunha TF; Bechara LR; Moreira JB
    Exp Physiol; 2014 Apr; 99(4):616-20. PubMed ID: 24273305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
    Anker SD; Chua TP; Ponikowski P; Harrington D; Swan JW; Kox WJ; Poole-Wilson PA; Coats AJ
    Circulation; 1997 Jul; 96(2):526-34. PubMed ID: 9244221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional adiponectin resistance and exercise intolerance in heart failure.
    Van Berendoncks AM; Conraads VM
    Curr Heart Fail Rep; 2011 Jun; 8(2):113-22. PubMed ID: 21424675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible synergism of physical exercise and ghrelin-agonists in patients with cachexia associated with chronic heart failure.
    Invernizzi M; Carda S; Cisari C;
    Aging Clin Exp Res; 2014 Aug; 26(4):341-51. PubMed ID: 24347122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise intolerance in congestive heart failure: a lesson in exercise physiology.
    Brubaker PH
    J Cardiopulm Rehabil; 1997; 17(4):217-21. PubMed ID: 9271764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac cachexia.
    Anker SD; Steinborn W; Strassburg S
    Ann Med; 2004; 36(7):518-29. PubMed ID: 15513302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.
    Middlekauff HR
    Circ Heart Fail; 2010 Jul; 3(4):537-46. PubMed ID: 20647489
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic heart failure-related myopathy and exercise training: a developing therapy for heart failure symptoms.
    Corrà U; Mezzani A; Giannuzzi P; Tavazzi L
    Curr Probl Cardiol; 2003 Sep; 28(9):521-47. PubMed ID: 14657840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.